Accutane risk management program
As of April 10, only Accutane (isotretinoin) prescriptions with "qualification stickers" will be dispensed. The stickers are intended to certify that the physician has followed the pregnancy prevention steps required in revised Accutane labeling. The updated pregnancy prevention program is being phased in over three months (1"The Pink Sheet" Nov. 5, 2001, p. 3). Accutane is poised to lose its patent exclusivity on Feb. 7...
You may also be interested in...
Accutane prescribers must register with Roche to receive "qualification stickers" under the company's updated pregnancy prevention program
Redirection of healthcare resources to tackle COVID-19 is posing huge challenges for TB care and researchers in the area. Companies like J&J have stepped in to support, among other aspects, innovative community-based solutions to ensure continuity of care for drug resistant-TB patients amid the pandemic.
After a high-profile launch early this year, first-mover Perrigo has recalled its albuterol sulfate aerosol in the US following complaints of inhalers failing to dispense due to “clogging.” The firm has revealed the expected financial impact of the move as well as commenting on how long it expects the product to be off the market, during which albuterol rivals Cipla and Lupin could benefit.